A Food Security Intervention for the Prevention of Cancer in Low-income Families
Not Applicable
Not yet recruiting
- Conditions
- Obesity-Related Malignant Neoplasm
- First Posted Date
- 2025-06-26
- Last Posted Date
- 2025-06-26
- Lead Sponsor
- Roswell Park Cancer Institute
- Target Recruit Count
- 50
- Registration Number
- NCT07039630
- Locations
- 🇺🇸
Roswell Park Cancer Institute, Buffalo, New York, United States
GT103 in Combination With Pembrolizumab for the Treatment of Advanced or Metastatic STK11 Mutant Non-Small Cell Lung Cancer
Phase 2
Not yet recruiting
- Conditions
- Advanced Lung Non-Small Cell CarcinomaMetastatic Lung Non-Small Cell CarcinomaStage III Lung Cancer AJCC v8Stage IV Lung Cancer AJCC v8
- Interventions
- Biological: Anti-CFH Monoclonal Antibody GT103Procedure: Biopsy ProcedureProcedure: Biospecimen CollectionProcedure: Computed TomographyProcedure: Echocardiography TestProcedure: Magnetic Resonance Imaging
- First Posted Date
- 2025-06-12
- Last Posted Date
- 2025-06-12
- Lead Sponsor
- Roswell Park Cancer Institute
- Target Recruit Count
- 28
- Registration Number
- NCT07017829
- Locations
- 🇺🇸
Roswell Park Cancer Institute, Buffalo, New York, United States
Olanzapine for Managing Anorexia in Head and Neck Cancer Patients Undergoing Chemoradiation, MACRO Trial
Phase 2
Not yet recruiting
- Conditions
- Cancer-Associated AnorexiaHead and Neck Squamous Cell CarcinomaNeck Squamous Cell Carcinoma of Unknown Primary
- Interventions
- First Posted Date
- 2025-05-29
- Last Posted Date
- 2025-05-29
- Lead Sponsor
- Roswell Park Cancer Institute
- Target Recruit Count
- 66
- Registration Number
- NCT06995508
- Locations
- 🇺🇸
Roswell Park Cancer Institute, Buffalo, New York, United States
Alpha-Stim AID® Together With Life Coaching for the Support of Burnout Symptoms in Healthcare Workers
Not Applicable
Not yet recruiting
- Conditions
- Psychiatric Disorder
- First Posted Date
- 2025-05-18
- Last Posted Date
- 2025-05-28
- Lead Sponsor
- Roswell Park Cancer Institute
- Target Recruit Count
- 40
- Registration Number
- NCT06977503
- Locations
- 🇺🇸
Roswell Park Cancer Institute, Buffalo, New York, United States
Autologous CAR T Cells Targeting GPC3 (RPCAR01) for the Treatment of Advanced or Metastatic GPC3 Expressing Hepatocellular Carcinoma
Phase 1
Not yet recruiting
- Conditions
- Advanced Hepatocellular CarcinomaMetastatic Hepatocellular CarcinomaRecurrent Hepatocellular CarcinomaRefractory Hepatocellular CarcinomaStage III Hepatocellular Carcinoma AJCC v8Stage IV Hepatocellular Carcinoma AJCC v8
- Interventions
- Biological: Anti-GPC3-CAR Autologous T LymphocytesProcedure: Biospecimen CollectionProcedure: Computed TomographyProcedure: Echocardiography TestProcedure: LeukapheresisProcedure: Magnetic Resonance ImagingProcedure: Multigated Acquisition Scan
- First Posted Date
- 2025-05-13
- Last Posted Date
- 2025-06-22
- Lead Sponsor
- Roswell Park Cancer Institute
- Target Recruit Count
- 24
- Registration Number
- NCT06968195
- Locations
- 🇺🇸
Roswell Park Cancer Institute, Buffalo, New York, United States
Photoimmunotherapy With ASP-1929 and Cemiplimab for the Treatment of Refractory, Inoperable, and Metastatic Stage IIIB-IV Non-small Cell Lung Cancer
Phase 2
Not yet recruiting
- Conditions
- Lung Non-Small Cell CarcinomaMetastatic Lung Non-Small Cell CarcinomaRefractory Lung Non-Small Cell CarcinomaStage IIIB Lung Cancer AJCC v8Stage IIIC Lung Cancer AJCC v8Stage IV Lung Cancer AJCC v8
- Interventions
- Procedure: Biospecimen CollectionProcedure: Computed TomographyOther: Electronic Health Record ReviewProcedure: Endobronchial Ultrasound BronchoscopyProcedure: Magnetic Resonance ImagingProcedure: PhotoimmunotherapyProcedure: Positron Emission TomographyProcedure: Robotic BronchoscopyProcedure: Video-Assisted Thoracic Surgery
- First Posted Date
- 2025-04-24
- Last Posted Date
- 2025-05-14
- Lead Sponsor
- Roswell Park Cancer Institute
- Target Recruit Count
- 27
- Registration Number
- NCT06943664
- Locations
- 🇺🇸
Roswell Park Cancer Institute, Buffalo, New York, United States
A Financial Intervention (Financial Compass) to Identify and Address Financial Hardship Among Head and Neck Cancer Patients, Financial Compass Trial
Not Applicable
Recruiting
- Conditions
- Head and Neck Carcinoma
- First Posted Date
- 2025-03-26
- Last Posted Date
- 2025-04-16
- Lead Sponsor
- Roswell Park Cancer Institute
- Target Recruit Count
- 44
- Registration Number
- NCT06896695
- Locations
- 🇺🇸
Roswell Park Cancer Institute, Buffalo, New York, United States
Home-Based Respiratory Muscle Training Intervention for Reducing Symptoms in Stage I-III Lung Cancer Survivors
Not Applicable
Not yet recruiting
- Conditions
- Localized Lung CarcinomaStage I Lung Cancer AJCC v8Stage II Lung Cancer AJCC v8Stage III Lung Cancer AJCC v8
- First Posted Date
- 2025-03-25
- Last Posted Date
- 2025-03-30
- Lead Sponsor
- Roswell Park Cancer Institute
- Target Recruit Count
- 100
- Registration Number
- NCT06869447
- Locations
- 🇺🇸
Roswell Park Cancer Institute, Buffalo, New York, United States
Genetically Engineered Cells (CD83 CAR T Cells) for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia
Phase 1
Not yet recruiting
- Conditions
- Recurrent Acute Myeloid LeukemiaRefractory Acute Myeloid Leukemia
- Interventions
- Drug: Autologous Anti-CD83 CAR T-cellsProcedure: Biospecimen CollectionProcedure: Chest RadiographyProcedure: Computed TomographyProcedure: EchocardiographyProcedure: LeukapheresisProcedure: Lumbar PunctureProcedure: Positron Emission TomographyOther: Questionnaire Administration
- First Posted Date
- 2025-03-12
- Last Posted Date
- 2025-06-22
- Lead Sponsor
- Roswell Park Cancer Institute
- Target Recruit Count
- 26
- Registration Number
- NCT06871410
- Locations
- 🇺🇸
Roswell Park Cancer Institute, Buffalo, New York, United States
Nemtabrutinib and Pembrolizumab for the Treatment of Richter Transformation, Diffuse Large B-cell Lymphoma Subtype
Phase 2
Not yet recruiting
- Conditions
- Richter SyndromeTransformed Chronic Lymphocytic Leukemia to Diffuse Large B-Cell LymphomaChronic Lymphocytic Leukemia
- Interventions
- Procedure: Biospecimen CollectionProcedure: Bone Marrow BiopsyProcedure: Computed TomographyProcedure: EchocardiographyProcedure: Multigated Acquisition ScanProcedure: Positron Emission TomographyOther: Questionnaire Administration
- First Posted Date
- 2025-03-07
- Last Posted Date
- 2025-03-10
- Lead Sponsor
- Roswell Park Cancer Institute
- Target Recruit Count
- 32
- Registration Number
- NCT06863402
- Locations
- 🇺🇸
Roswell Park Cancer Institute, Buffalo, New York, United States